... walkAvailability for the duration of the entire study periodExclusion History of underlying inflammatory arthropathy or severe rheumatoid arthritisHyperuricaemia (>440 μmol/l) and/ or past history of ... inserum and haematological parameters, and urine analysis wereperformed to evaluate the safety of 5-Loxin® in OA patients.Results Seventy patients completed the study. At the end of the study, both ... properties byinhibiting the 5-lipoxygenase enzyme. A 90-day, double-blind,randomized, placebo-controlled study was conducted to evaluate the efficacy and safety of 5-Loxin® in the treatment of osteoarthritis...